Levorphanol tablets 2 mg had a market value of roughly $60.9 million, for the 12 months ended May 2020, according to IQVIA, although actual generic market values are expected to be lower.
Empagliflozin and linagliptin tablets are indicated as an adjunct to diet and exercise to improve glycemic control in adults with Type 2 diabetes mellitus.